症状性脊柱转移瘤行内固定减瘤手术的结局如何及疗效能维持多久:全球脊柱肿瘤研究组数据库的亚组分析
基于全球脊柱肿瘤研究组前瞻性多中心数据库,分析914例接受减压减瘤加内固定手术的症状性脊柱转移瘤患者。术后12个月生存率为56.3%,手术改善EQ-5D健康状态和NRS疼痛评分并维持至随访结束;25.0%患者首次随访Frankel评分改善,但12个月时18.8%出现神经功能恶化。
要点
- 减压减瘤加内固定手术可改善疼痛评分和生活质量,效果维持至术后2年。
- 术后12个月生存率为56.3%。
- 25.0%患者首次随访Frankel评分改善,12个月时18.8%出现神经功能恶化。
核心结论
- 姑息性减瘤加内固定手术在所有Tomita和Tokuhashi评分类别中均有实施,术后疼痛评分降低、生活质量改善并维持至术后2年。
- 部分患者初始改善后于1年内出现神经功能恶化,但多数患者保持稳定。
研究设计与样本
- 全球脊柱肿瘤研究组(GSTSG)数据库为前瞻性多中心连续患者数据存储库,纳入因症状性脊柱转移瘤接受手术的患者。
- 本分析选取其中接受减压减瘤手术加内固定的患者,分析术前肿瘤类型、Tomita和Tokuhashi评分、EQ-5D、Frankel、Karnofsky评分及术后并发症、生存和术后3、6、12、24个月的EQ-5D、Frankel、Karnofsky及疼痛数字评分(NRS)。
- 共914例患者接受减压减瘤手术加内固定,并有随访记录直至死亡或术后2年。
主要发现
- 术前Karnofsky功能指数中位数为70。
- 656例(71.8%)有内脏转移,490例(53.6%)有椎外骨转移。
- Tomita评分高于5分者占49.1%,低于或等于5分者占50.9%;Tokuhashi评分低于或等于8分者占46.3%,高于8分者占53.7%。
- 术后12个月生存率为56.3%。
- 手术使EQ-5D健康状态改善、NRS疼痛评分降低,并维持整个随访期;首次随访时25.0%患者Frankel评分改善,但至12个月时18.8%患者出现神经功能恶化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The benefits of surgery for symptomatic spinal metastases have been demonstrated, largely based on series of patients undergoing debulking and instrumentation operations. However, as cancer treatments improve and overall survival lengths increase, the incidence of recurrent spinal cord compression after debulking may increase. The aim of the current paper is to document the postoperative evolution of neurological function, pain, and quality of life following debulking and instrumentation in the Global Spine Tumor Study Group (GSTSG) database. METHODS: The GSTSG database is a prospective multicenter data repository of consecutive patients that underwent surgery for a symptomatic spinal metastasis. For the present analysis, patients were selected from the database that underwent decompressive debulking surgery with instrumentation. Preoperative tumor type, Tomita and Tokuhashi scores, EQ-5D, Frankel, Karnofsky, and postoperative complications, survival, EQ-5D, Frankel, Karnofsky, and pain numeric rating scores (NRS) at 3, 6, 12, and 24 months were analyzed. RESULTS: A total of 914 patients underwent decompressive debulking surgery with instrumentation and had documented follow-up until death or until 2 years post surgery. Median preoperative Karnofsky performance index was 70. A total of 656 patients (71.8%) had visceral metastases and 490 (53.6%) had extraspinal bone metastases. Tomita scores were evenly distributed above (49.1%) and below or equal to 5 (50.9%), and Tokuhashi scores almost evenly distributed below or equal to 8 (46.3%) and above 8 (53.7%). Overall, 12-month survival after surgery was 56.3%. The surgery resulted in EQ-5D health status improvement and NRS pain reduction that was maintained throughout follow-up. Frankel scores improved at first follow-up in 25.0% of patients, but by 12 months neurological deterioration was observed in 18.8%. CONCLUSION: We found that palliative debulking and instrumentation surgeries were performed throughout all Tomita and Tokuhashi categories. These surgeries reduced pain scores and improved quality of life up to 2 years after surgery. After initial improvement, a proportion of patients experienced neurological deterioration by 1 year, but the majority of patients remained stable.
引用
- Depreitere B, Ricciardi F, Arts M, et al. How good are the outcomes of instrumented debulking operations for symptomatic spinal metastases and how long do they stand? A subgroup analysis in the global spine tumor study group database. Acta Neurochir (Wien). 2020. PMID: 31953690. doi:10.1007/s00701-019-04197-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。